ArticlePain research & management2026
Efficacy of Suprascapular Nerve Block and Pulsed Radiofrequency for Chronic Shoulder Pain in Parkinson's Disease.
Article in Pain research & management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of Suprascapular Nerve Block and Pulsed Radiofrequency for Chronic Shoulder Pain in Parkinson's Disease.Pain research & management · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundShoulder pain is a frequent and clinically relevant nonmotor symptom in Parkinson's disease (PD). Although suprascapular nerve block and pulsed radiofrequency (PRF) are used effectively for chronic shoulder pain in the general population, their therapeutic effects in patients with PD have not been clearly established.
objectiveTo assess the clinical efficacy of suprascapular nerve block combined with PRF in PD-related shoulder pain and its association with rigidity severity.
methodsThis prospective, matched cohort study included 20 patients with PD and 20 age- and sex-matched controls with chronic shoulder pain consistent with subacromial pain syndrome. All participants underwent ultrasound-guided suprascapular nerve block combined with PRF. Pain intensity was assessed using the Numeric Rating Scale (NRS), and shoulder-related pain and disability were evaluated using the Shoulder Pain and Disability Index (SPADI). Outcomes were recorded at baseline and during follow-up. Associations between rigidity severity, levodopa equivalent daily dose (LEDD), and changes in clinical outcomes were analyzed using Spearman and partial correlation analyses.
resultsBoth groups demonstrated significant reductions in NRS and SPADI scores following the intervention (all p < 0.01). Although overall pain and disability improved, SPADI pain scores remained significantly higher in the PD group at follow-up. Greater rigidity severity was consistently associated with reduced improvement in pain- and disability-related outcomes, ranging from trend-level to statistically significant correlations.
conclusionSuprascapular nerve block combined with PRF provides meaningful pain relief in patients with PD and chronic shoulder pain. However, greater rigidity severity appears to limit clinical improvement, suggesting that disease-specific motor features play an important role in shaping pain burden and response to peripheral interventions in PD. These findings highlight the need for multimodal pain management strategies addressing both peripheral and central disease-related factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.